With 0.53 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.2 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $43.93 whereas the lowest price it dropped to was $40.8393. The 52-week range on CTEV shows that it touched its highest point at $74.07 and its lowest point at $11.43 during that stretch. It currently has a 1-year price target of $71.00. Beta for the stock currently stands at 0.50.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CTEV was up-trending over the past week, with a rise of 1.40%, but this was down by -19.66% over a month. Three-month performance dropped to -18.16% while six-month performance fell -0.41%. The stock gained 193.91% in the past year, while it has gained 245.86% so far this year. A look at the trailing 12-month EPS for CTEV yields -20.94 with Next year EPS estimates of -13.60. For the next quarter, that number is -3.98. This implies an EPS growth rate of 83.94% for this year and 16.92% for next year.
Float and Shares Shorts:
At present, 16.51 million CTEV shares are outstanding with a float of 8.86 million shares on hand for trading. On 2025-12-15, short shares totaled 0.78 million, which was 475.0 higher than short shares on 1763078400. In addition to Mr. Travis S. Dalton as the firm’s CEO, President & Chairman, Mr. Douglas M. Garis serves as its Executive VP & CFO.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-09-30, CTEV reported revenue of $245959000.0 and operating income of $10067000.0. The EBITDA in the recently reported quarter was $123156000.0 and diluted EPS was -$4.23.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With CTEV analysts setting a high price target of 90.0 and a low target of 80.0, the average target price over the next 12 months is 85.0. Based on these targets, CTEV could surge 107.18% to reach the target high and rise by 84.16% to reach the target low. Reaching the average price target will result in a growth of 95.67% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$80.51418 being high and -$80.91364 being low. For CTEV, this leads to a yearly average estimate of -$80.71391. The surprise factor in the prior quarter was -$3.83. Based on analyst estimates, the high estimate for the next quarter is -$3.75 and the low estimate is -$3.75. The average estimate for the next quarter is thus -$3.75.
